You are here

Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2010 R21 CA137703 RFA-CA-09-008 LIU, GUODONG NORTH DAKOTA STATE UNIVERSITY DEVELOPMENT OF A HAND-HELD CANCER BIOMARKER MONITOR Complete
2014 R33 CA183659 RFA-CA-13-002 ROBINSON, WILLIAM H STANFORD UNIVERSITY LARGE-SCALE CHARACTERIZATION OF ANTI-CANCER ANTIBODY RESPONSES IN LUNG ADENOCARCI Complete
2001 R33 CA083204 PAR-98-067 SHACKNEY, STANLEY E ALLEGHENY-SINGER RESEARCH INSTITUTE MOLECULAR PROFILING OF CELLS BY LASER SCANNING CYTOMETRY Complete
2003 R33 CA095996 PAR-01-106 RONINSON, IGOR B ORDWAY RESEARCH INSTITUTE, INC. FUNCTION-BASED SELECTION OF TARGET GENES IN TUMOR CELLS Complete
2007 R21 CA126700 RFA-CA-07-001 DING, ZHIYONG UT MD ANDERSON CANCER CTR EFFECTIVE MAMMALIAN TWO HYBRID SCREENING APPROACH Complete
2009 R33 CA137673 RFA-CA-08-008 BEEBE, DAVID J UNIVERSITY OF WISCONSIN-MADISON MICROCHANNEL CELL-BASED ASSAYS TO ENABLE CANCER RESEARCH Complete
2013 R33 CA177461 RFA-CA-12-003 FURDUI, CRISTINA MARIA WAKE FOREST UNIVERSITY HEALTH SCIENCES NEW REAGENTS FOR TRACKING PROTEIN OXIDATION IN CELLS BY MS AND IMAGING METHODS Complete
2016 R43 CA203647 PAR-13-327 LIM, MARK AMBERGEN, INC Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays Complete
2000 R41 CA084693 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION MONOLITHIC MULTI-CAPILLARY ARRAYS TO SEQUENCE DNA Complete
2002 R43 CA096053 PAR-01-105 BECKER, CHRISTOPHER SURROMED, INC. AFFINITY MASS TAGS FOR DIFFERENTIAL PHENOTYPING Complete
2006 R21 CA120732 RFA-CA-06-003 MEYER, TOBIAS STANFORD UNIVERSITY DISSECTION OF THE MODULAR STRUCTURE OF CANCER SIGNALING SYSTEMS Complete
2009 R21 CA138295 RFA-CA-08-006 LESSNICK, STEPHEN L. UNIVERSITY OF UTAH ANTIBODY-BASED DETECTION OF TRANSLOCATIONS IN PEDIATRIC CANCER Complete
2012 R21 CA173205 RFA-CA-12-002 TAO, NONGJIAN ARIZONA STATE UNIVERSITY-TEMPE CAMPUS CHARGE SENSITIVE OPTICAL DETECTION FOR HIGH THROUGHPUT STUDY OF SMALL MOLECULES Complete
2016 R21 CA204706 RFA-CA-15-002 BURGETT, ANTHONY WG UNIVERSITY OF OKLAHOMA NORMAN MASS SPECTROMETRY DETECTION OF DRUGS IN SINGLE BLADDER CANCER CELLS FROM PATIENTS Complete
2000 R21 CA088326 PAR-99-100 WEISSMAN, SHERMAN MORTON YALE UNIVERSITY DISPLAY METHODS FOR SURVEYING MUTATIONS Complete
2002 R21 CA094340 PAR-99-102 MEHTA, ANAND S THOMAS JEFFERSON UNIVERSITY IDENTIFICATION OF SERUM GLYCOSYLATION MARKERS OF HCC Complete
2005 R21 CA116079 RFA-CA-05-003 LIZARDI, PAUL M. YALE UNIVERSITY GLOBAL DNA METHYLATION PROFILES OF HEAD AND NECK CANCERS Complete
2008 R21 CA126764 RFA-CA-07-035 KRON, STEPHEN J UNIVERSITY OF CHICAGO MALDI IMAGING OF CANCER SIGNALING SIGNATURES Complete
2011 R21 CA140036 RFA-CA-10-005 DECAPRIO, ANTHONY P FLORIDA INTERNATIONAL UNIVERSITY PLATFORM FOR HIGH-THROUGHPUT ANALYSIS OF PROTEIN ADDUCTS FOR CARCINOGEN EXPOSURE Complete
2015 R21 CA183623 RFA-CA-14-005 PENNO, MARGARET B JOHNS HOPKINS UNIVERSITY PEDIATRIC CANCER SALVIA BIOREPOSITORY Complete
1999 R43 CA081903 PAR-98-066 TS'O, PAUL O. P. CCC DIAGNOSTICS, LLC ISOLATION AND PROFILING OF CIRCULATING PC CELLS IN BLOOD Complete
2001 R43 CA093155 PAR-99-101 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS WHOLE GENOME METHYLATION ASSAY Complete
2004 R43 CA105542 PAR-01-105 PARIS, MARK J VACCINEX, INC. FUNCTIONAL IDENTIFICATION OF CANCER REGULATORS Complete
2007 R33 CA120726 RFA-CA-07-002 MOORE, PATRICK S. UNIVERSITY OF PITTSBURGH AT PITTSBURGH EMERGING TECHNOLOGIES APPLIED TO THE DISCOVERY OF HUMAN TUMOR VIRUSES Complete
2010 R21 CA151128 RFA-CA-09-008 SOUSA, RUI J. UNIVERSITY OF TEXAS HLTH SCIENCE CENTER DEVELOPMENT OF IMAGING REAGENTS TO MONITOR GTP LEVELS AND GTP/GDP RATIOS IN VIVO Complete
2014 R33 CA177333 RFA-CA-13-002 FEDERSPIEL, MARK J MAYO CLINIC ROCHESTER VALIDATING TECHNOLOGY TO OPTIMIZE ANTIBODY AFFINITY FOR TARGETING THERAPEUTICS Complete
2017 R33 CA212697 RFA-CA-16-002 KLEIN, ALLON MOSHE HARVARD MEDICAL SCHOOL Droplet microfluidic technology for single cell cancer genomics Complete
2001 R33 CA084691 PAR-98-067 MELDRUM, DEIRDRE R. UNIVERSITY OF WASHINGTON AUTOMATED MINIMAL RESIDUAL DISEASE QUANTIFICATION Complete
2003 R41 CA103103 PAR-01-105 SANTANGELO, PHILIP J VIVONETICS, INC. IN VIVO GENE EXPRESSION IMAGING FOR CANCER ANALYSIS Complete
2007 R21 CA122884 RFA-CA-07-001 BIEBERICH, CHARLES J. UNIVERSITY OF MARYLAND BALT CO CAMPUS AN INNOVATIVE APPROACH FOR PROFILING PROTEIN KINASE SUBSTRATES Complete
2009 R33 CA134304 RFA-CA-08-008 SHI, HUIDONG GEORGIA REGENTS UNIVERSITY APPLICATION OF 454 SEQUENCING TO CANCER EPIGENOMICS Complete
2013 R33 CA177462 RFA-CA-12-003 BAILEY, RYAN C UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN MESO-PLEX MIRNA AND PROTEIN PROFILING FOR CANCER DIAGNOSTICS USING CHIP-INTEGRATE Complete
2016 R43 CA203681 PAR-13-327 KING, JEFFREY S VIROGENOMICS BIODEVELOPMENT, INC. Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia Complete
2000 R43 CA081787 PAR-99-101 BUTT, TAUSEEF R. LIFESENSORS, INC. LIVESENSORS FOR MOLECULAR PROFILING IN PROSTATE CANCER Complete
2002 R43 CA096056 PAR-01-105 STRAUME, TORE GENMETRIX, LLC ASSAY FOR DETECTION OF CANCER CHROMOSOME ABNORMALITIES Complete
2006 R21 CA122864 RFA-CA-06-003 FERRARI, MAURO UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON NANOPARTICLES FOR HARVESTING AND TARGETING ANGIOGENIC PROTEINS Complete
2009 R21 CA138280 RFA-CA-08-006 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INST TECHNOLOGY FOR SENSITIVE AND RELIABLE MUTATIONAL PROFILING IN PANCREATIC CANCER Complete
2012 R21 CA173303 RFA-CA-12-002 CARTEGNI, LUCA SLOAN-KETTERING INST CAN RESEARCH CONTROLLED PREMATURE TERMINATION OF TRANSLATION TO GENERATE DESIGNATED TRUNCATED Complete
2016 R21 CA206904 RFA-CA-15-002 CHANG, HSUEH-CHIA UNIVERSITY OF NOTRE DAME A SOLID-STATE NANOPORE MIRNA QUANTIFICATION TECHNOLOGY Complete
2000 R21 CA088351 PAR-99-100 FU, XIANG-DONG UNIVERSITY OF CALIFORNIA SAN DIEGO CANCER CLASSIFICATION BASED ON MRNA ISOFORMS Complete
2002 R33 CA096309 PAR-01-104 LI, HONGHUA UNIV OF MED/DENT NJ-R W JOHNSON MED SCH A GENETIC APPROACH TO GENOME-SCALE ANALYSIS OF CANCERS Complete
2005 R21 CA116060 RFA-CA-05-003 KANDEL, EUGENE S CLEVELAND CLINIC LERNER COL/MED-CWRU REVERSIBLE PROMOTER-INSERTION FOR IN VIVO STUDIES OF MELANOMA Complete
2008 R21 CA126664 RFA-CA-07-035 BARBAS, CARLOS F SCRIPPS RESEARCH INSTITUTE ZINC FINGER RECOMBINASES FOR ENDOGENOUS GENOME TAILORING Complete
2011 R21 CA147922 RFA-CA-10-005 SANTANGELO, PHILIP J GEORGIA INSTITUTE OF TECHNOLOGY CHARACTERIZING GENE REGULATION WITH SINGLE MOLECULE SENSITIVE PROBES Complete
2015 R21 CA182375 RFA-CA-14-005 SOHN, LYDIA L UNIVERSITY OF CALIFORNIA BERKELEY ISOLATING CIRCULATING TUMOR CELLS Complete
1999 R43 CA081949 PAR-98-066 OLINER, JONATHAN D AFFYMETRIX, INC. REVERSE-ENGINEERING SIGNAL TRANSDUCTION NETWORKS Complete
2001 R43 HL069675 PAR-99-101 WILLETT, CATHERINE E PHYLONIX PHARMACEUTICALS, INC. ASSAY FOR IDENTIFYING ANGIOGENIC DRUG TARGETS Complete
2004 R43 CA107764 PAR-01-105 VYKOUKAL, JODY V ADEPTAS, INC. RARE CELL ISOLATION FOR MORPHOLOGICAL & MOLECULAR STUDY Complete
2007 R33 CA122900 RFA-CA-07-002 DOVICHI, NORMAN J UNIVERSITY OF WASHINGTON CHEMICAL CYTOMETRY FOR NEOPLASIA PROGNOSIS-BARRETT'S ESOPHAGUS Complete
2010 R21 CA140089 RFA-CA-09-008 JI, HANLEE P STANFORD UNIVERSITY MUTATION ANALYSIS OF PARAFFIN-EMBEDDED TUMORS WITH NEXT GENERATION SEQUENCING Complete

Pages